Institutional shares held 127 Million
1.51M calls
2.35M puts
Total value of holdings $8.53B
$102M calls
$158M puts
Market Cap $6.8B
102,220,000 Shares Out.
Institutional ownership 123.8%
# of Institutions 416


Latest Institutional Activity in GH

Top Purchases

Q2 2025
Millennium Management LLC Shares Held: 2.72M ($181M)
Q2 2025
Ark Investment Management LLC Shares Held: 2.82M ($188M)
Q2 2025
Norges Bank Shares Held: 1.23M ($82M)
Q2 2025
Price T Rowe Associates Inc Shares Held: 1.77M ($117M)
Q2 2025
Franklin Resources Inc Shares Held: 2.32M ($154M)

Top Sells

Q2 2025
Cadian Capital Management, LP Shares Held: 3.18M ($211M)
Q2 2025
Deep Track Capital, LP Shares Held: 4.25M ($283M)
Q2 2025
Ubs Group Ag Shares Held: 1.18M ($78.7M)
Q2 2025
Voloridge Investment Management, LLC Shares Held: 173K ($11.5M)
Q2 2025
Point72 Asset Management, L.P. Shares Held: 56.3K ($3.74M)

About GH

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.


Insider Transactions at GH

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
823K Shares
From 17 Insiders
Exercise of conversion of derivative security 815K shares
Other acquisition or disposition 8.44K shares
Sell / Disposition
757K Shares
From 16 Insiders
Open market or private sale 387K shares
Payment of exercise price or tax liability 361K shares
Other acquisition or disposition 8.44K shares

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH